Correlation Between ProSomnus, Common and Neuropace
Can any of the company-specific risk be diversified away by investing in both ProSomnus, Common and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ProSomnus, Common and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ProSomnus, Common Stock and Neuropace, you can compare the effects of market volatilities on ProSomnus, Common and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ProSomnus, Common with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of ProSomnus, Common and Neuropace.
Diversification Opportunities for ProSomnus, Common and Neuropace
0.45 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ProSomnus, and Neuropace is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding ProSomnus, Common Stock and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and ProSomnus, Common is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ProSomnus, Common Stock are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of ProSomnus, Common i.e., ProSomnus, Common and Neuropace go up and down completely randomly.
Pair Corralation between ProSomnus, Common and Neuropace
If you would invest 771.00 in Neuropace on August 28, 2024 and sell it today you would earn a total of 295.00 from holding Neuropace or generate 38.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 4.76% |
| Values | Daily Returns |
ProSomnus, Common Stock vs. Neuropace
Performance |
| Timeline |
| ProSomnus, Common Stock |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Neuropace |
ProSomnus, Common and Neuropace Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ProSomnus, Common and Neuropace
The main advantage of trading using opposite ProSomnus, Common and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ProSomnus, Common position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.| ProSomnus, Common vs. LivaNova PLC | ProSomnus, Common vs. Electromed | ProSomnus, Common vs. Orthopediatrics Corp | ProSomnus, Common vs. SurModics |
| Neuropace vs. Heartbeam | Neuropace vs. EUDA Health Holdings | Neuropace vs. Nutex Health | Neuropace vs. Healthcare Triangle |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |